O	0	11	Measurement	Measurement	NN	B-NP
O	12	14	of	of	IN	B-PP
B-Organism_substance	15	20	serum	serum	NN	B-NP
O	21	33	glycosylated	glycosylate	VBN	I-NP
O	34	42	proteins	protein	NNS	I-NP
O	43	46	and	and	CC	O
O	47	59	glycosylated	glycosylate	VBN	B-NP
O	60	63	low	low	JJ	I-NP
O	64	71	density	density	NN	I-NP
O	72	83	lipoprotein	lipoprotein	NN	I-NP
O	84	92	fraction	fraction	NN	I-NP
O	93	95	in	in	IN	B-PP
O	96	104	diabetes	diabetes	NN	B-NP
O	105	113	mellitus	mellitus	NN	I-NP
O	113	114	.	.	.	O

O	115	116	A	A	DT	B-NP
O	117	123	simple	simple	JJ	I-NP
O	124	130	method	method	NN	I-NP
O	131	134	was	be	VBD	B-VP
O	135	144	developed	develop	VBN	I-VP
O	145	148	for	for	IN	B-PP
O	149	159	estimating	estimate	VBG	B-VP
B-Organism_substance	160	165	serum	serum	NN	B-NP
O	166	178	glycosylated	glycosylate	VBN	I-NP
O	179	186	protein	protein	NN	I-NP
O	187	193	levels	level	NNS	I-NP
O	194	199	using	use	VBG	B-VP
O	200	203	gel	gel	NN	B-NP
O	204	214	filtration	filtration	NN	I-NP
O	215	219	with	with	IN	B-PP
O	220	223	Bio	Bio	NNP	B-NP
O	223	224	-	-	HYPH	I-NP
O	224	227	Gel	Gel	NNP	I-NP
O	228	230	P6	P6	NN	I-NP
O	231	233	by	by	IN	B-PP
O	234	245	determining	determine	VBG	B-VP
O	246	249	the	the	DT	B-NP
O	250	257	protein	protein	NN	I-NP
O	258	261	and	and	CC	I-NP
O	262	267	sugar	sugar	NN	I-NP
O	268	275	content	content	NN	I-NP
O	276	278	in	in	IN	B-PP
O	279	282	the	the	DT	B-NP
O	283	287	void	void	JJ	I-NP
O	288	294	volume	volume	NN	I-NP
O	295	303	fraction	fraction	NN	I-NP
O	303	304	.	.	.	O

O	305	308	The	The	DT	B-NP
O	309	321	glycosylated	glycosylate	VBN	I-NP
O	322	329	protein	protein	NN	I-NP
O	330	336	levels	level	NNS	I-NP
O	337	338	(	(	(	O
O	338	341	GSP	GSP	NN	B-NP
O	341	342	)	)	)	O
O	343	353	correlated	correlate	VBD	B-VP
O	354	358	well	well	RB	B-ADVP
O	359	363	with	with	IN	B-PP
O	364	371	fasting	fast	VBG	B-VP
B-Organism_substance	372	377	blood	blood	NN	B-NP
O	378	383	sugar	sugar	NN	I-NP
O	384	390	levels	level	NNS	I-NP
O	391	394	and	and	CC	O
O	395	407	glycosylated	glycosylate	VBN	B-NP
O	408	415	albumin	albumin	NN	I-NP
O	416	421	level	level	NN	I-NP
O	422	423	(	(	(	O
O	423	424	G	G	NN	B-NP
O	424	425	-	-	HYPH	B-NP
O	425	428	ALB	ALB	NN	I-NP
O	428	429	)	)	)	O
O	430	440	determined	determine	VBN	B-VP
O	441	443	by	by	IN	B-PP
O	444	452	affinity	affinity	NN	B-NP
O	453	467	chromatography	chromatography	NN	I-NP
O	468	472	with	with	IN	B-PP
O	473	477	Blue	Blue	JJ	B-NP
O	478	487	Sepharose	Sepharose	NN	I-NP
O	488	492	CL6B	CL6B	NN	I-NP
O	492	493	.	.	.	O

O	494	497	The	The	DT	B-NP
O	498	511	glycosylation	glycosylation	NN	I-NP
O	512	517	level	level	NN	I-NP
O	518	520	of	of	IN	B-PP
O	521	528	heparin	heparin	NN	B-NP
O	528	529	-	-	HYPH	B-NP
O	529	536	citrate	citrate	NN	I-NP
O	537	549	precipitable	precipitable	JJ	I-NP
O	550	558	fraction	fraction	NN	I-NP
O	559	561	of	of	IN	B-PP
B-Organism_substance	562	567	serum	serum	NN	B-NP
O	568	573	which	which	WDT	B-NP
O	574	587	predominantly	predominantly	RB	B-ADVP
O	588	597	contained	contain	VBD	B-VP
O	598	601	low	low	JJ	B-NP
O	602	609	density	density	NN	I-NP
O	610	621	lipoprotein	lipoprotein	NN	I-NP
O	622	623	(	(	(	O
O	623	624	G	G	NN	B-NP
O	624	625	-	-	HYPH	B-NP
O	625	628	LDL	LDL	NN	I-NP
O	628	629	)	)	)	O
O	630	634	also	also	RB	B-ADVP
O	635	645	correlated	correlate	VBD	B-VP
O	646	650	well	well	RB	B-ADVP
O	651	655	with	with	IN	B-PP
O	656	659	GSP	GSP	NN	B-NP
O	660	663	and	and	CC	I-NP
O	664	667	LDL	LDL	NN	I-NP
O	667	668	-	-	HYPH	B-NP
O	668	679	cholesterol	cholesterol	NN	I-NP
O	680	686	levels	level	NNS	I-NP
O	686	687	.	.	.	O

O	688	701	Significantly	Significantly	RB	B-NP
O	702	711	different	different	JJ	I-NP
O	712	718	values	value	NNS	I-NP
O	719	723	were	be	VBD	B-VP
O	724	732	obtained	obtain	VBN	I-VP
O	733	736	for	for	IN	B-PP
O	737	740	GSP	GSP	NN	B-NP
O	740	741	,	,	,	O
O	742	743	G	G	NN	B-NP
O	743	744	-	-	HYPH	I-NP
O	744	747	ALB	ALB	NN	I-NP
O	747	748	,	,	,	O
O	749	752	and	and	CC	O
O	753	754	G	G	NN	B-NP
O	754	755	-	-	HYPH	B-NP
O	755	758	LDL	LDL	NN	I-NP
O	759	766	between	between	IN	B-PP
O	767	774	normals	normal	NNS	B-NP
O	775	778	and	and	CC	I-NP
O	779	788	diabetics	diabetic	NNS	I-NP
O	788	789	.	.	.	O

